Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Journal of Medicinal Chemistry|August 10, 2001
Design, synthesis, and structure-activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitorsJ M Contreras, I Parrot, W Sippl, et al.Journal of Computer-Aided Molecular Design|June 8, 2001
Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitorsW Sippl, J M Contreras, I Parrot, et al.Journal of Medicinal Chemistry|August 1, 1991
GABA-uptake inhibitors: construction of a general pharmacophore model and successful prediction of a new representativeV N'Goka, G Schlewer, J M Linget, et al.Journal of Computer-Aided Molecular Design|July 1, 1997
Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinementH Bourdon, S Trumpp-Kallmeyer, H Schreuder, et al.Journal De Pharmacologie|April 1, 1986
[Pharmacologic profile of an original psychotropic drug. Minaprine: comparison with six reference antidepressives]P Worms, J P Kan, A Perio, et al.Pharmacology, Biochemistry, and Behavior|January 1, 1990
Anxiolytic and sedative properties of BW A78U, a novel anticonvulsant adenine derivativeM Willard, R Misslin, E Vogel, et al.Journal of Medicinal Chemistry|March 3, 1999
Aminopyridazines as acetylcholinesterase inhibitorsJ M Contreras, Y M Rival, S Chayer, et al.Journal of Medicinal Chemistry|February 17, 1998
5-HT3 antagonists derived from aminopyridazine-type muscarinic M1 agonistsY Rival, R Hoffmann, B Didier, et al.Journal of Neurochemistry|June 1, 1982
A high-affinity, Na+-dependent uptake system for gamma-hydroxybutyrate in membrane vesicles prepared from rat brainJ Benavides, J F Rumigny, J J Bourguignon, et al.Neuromuscular Disorders : NMD|May 18, 2004
Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegansAurélie Gaud, Jean-Marc Simon, Thomas Witzel, et al.Pageof 6